| Breakdown | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 66.49B | 68.17B | 72.42B | 80.08B |
| Gross Profit | 12.45B | 14.23B | 15.51B | 18.69B |
| EBITDA | -1.89B | -1.26B | 374.34M | 1.50B |
| Net Income | -2.79B | -1.94B | -829.47M | 625.74M |
Balance Sheet | ||||
| Total Assets | 15.34B | 19.79B | 16.36B | 26.86B |
| Cash, Cash Equivalents and Short-Term Investments | 1.42B | 4.83B | 877.09M | 5.20B |
| Total Debt | 5.28B | 5.04B | 5.78B | 10.92B |
| Total Liabilities | 13.73B | 13.12B | 14.02B | 23.63B |
| Stockholders Equity | 1.62B | 6.67B | 2.34B | 3.24B |
Cash Flow | ||||
| Free Cash Flow | -1.09B | -1.41B | -4.12B | 2.71B |
| Operating Cash Flow | -69.34M | -1.30B | -4.09B | 2.75B |
| Investing Cash Flow | -608.53M | -106.75M | 5.00B | -38.33M |
| Financing Cash Flow | -580.42M | 5.36B | -5.23B | -994.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥8.15B | 9.58 | ― | 3.59% | 0.52% | -3.73% | |
74 Outperform | ¥13.12B | 12.08 | ― | 1.57% | 5.93% | -14.18% | |
73 Outperform | ¥12.10B | 7.58 | ― | 2.21% | 14.35% | 11.49% | |
67 Neutral | ¥11.05B | 8.20 | ― | 1.46% | -0.02% | -7.09% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | ¥12.49B | ― | ― | 2.36% | 2.43% | 50.53% | |
43 Neutral | ¥10.05B | ― | ― | ― | -12.69% | 22.75% |